Michael J. Rider - 13 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Global General Counsel
Signature
Michael J. Rider
Issuer symbol
RMD
Transactions as of
13 Nov 2023
Net transactions value
-$63,065
Form type
4
Filing time
15 Nov 2023, 20:34:04 UTC
Previous filing
02 Nov 2023
Next filing
27 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $13,159 -92 -1.2% $143.60 7,308 13 Nov 2023 Direct F1
transaction RMD ResMed Common Stock Tax liability $16,883 -118 -1.6% $143.60 7,190 13 Nov 2023 Direct F2
transaction RMD ResMed Common Stock Tax liability $19,615 -137 -1.9% $143.60 7,054 13 Nov 2023 Direct F3
transaction RMD ResMed Common Stock Tax liability $13,408 -93 -1.3% $143.60 6,960 13 Nov 2023 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/21/2019.
F4 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020.
F5 Includes 41.402 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.